Publications by authors named "Oliver Ast"

Claim this Profile
A
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Laurence B Peterson, Charles J M Bell, Sarah K Howlett, Marcin L Pekalski, Kevin Brady, Oliver Ast

J Autoimmun· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p95HER2-T cell bispecific antibody for breast cancer treatment.
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, Cristina Bernadó Morales, Enrique J Arenas, Oliver Ast

Sci Transl Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.
Sabine Hoves, Chia-Huey Ooi, Carsten Wolter, Hadassah Sade, Stefan Bissinger, Oliver Ast, Yvonne Kienast

J Exp Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines.
Christian Klein, Inja Waldhauer, Valeria G Nicolini, Anne Freimoser-Grundschober, Tapan Nayak, Oliver Ast, Sebastian Neumann

Oncoimmunology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Marina Bacac, Tanja Fauti, Johannes Sam, Sara Colombetti, Tina Weinzierl, Oliver Ast, Sebastian Neumann

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
Charles J M Bell, Yongliang Sun, Urszula M Nowak, Jan Clark, Sarah Howlett, Oliver Ast

J Autoimmun· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering.
Andrzej Citkowicz, Harald Petry, Richard N Harkins, Oliver Ast, Linda Cashion

Anal Biochem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based delivery.
Harald Petry, Linda Cashion, Paul Szymanski, Oliver Ast, Ann Orme

J Interferon Cytokine Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics of HIV.
Oliver Ast, Wolfgang Lüke

Curr Opin Mol Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of virus-like particles for gene transfer.
Harald Petry, Claudia Goldmann, Oliver Ast, Wolfgang Lüke

Curr Opin Mol Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis